Evaluation of the Efficacy of a Bacteriophage in the Treatment of Pneumonia Induced by Multidrug ResistanceKlebsiella pneumoniaein Mice

Characterization of multidrug-resistant Klebsiella pneumoniae from Australia carrying blaNDM-1

(2013) Shereen Shoma et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone

(2013) Amos Adler et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Phage cocktails and the future of phage therapy

(2013) Benjamin K Chan et al.   Future Microbiology

Modulation of respiratory dendritic cells during Klebsiella pneumonia infection

(2013) Holger Hackstein et al.   RESPIRATORY RESEARCH

A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens

(2013) Xavier Wittebole et al.   Virulence

Efficacy of Bacteriophage Therapy in Experimental Sepsis and Meningitis Caused by a Clone O25b:H4-ST131 Escherichia coli Strain Producing CTX-M-15

(2012) Flavie Pouillot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia

(2012) Jose Bordon et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

A Method for Generation Phage Cocktail with Great Therapeutic Potential

(2012) Jingmin Gu et al.   PLoS One

What is needed for phage therapy to become a reality in Western medicine?

(2012) Harald Brüssow   VIROLOGY

Characterization of a T5-Like Coliphage, SPC35, and Differential Development of Resistance to SPC35 inSalmonella entericaSerovar Typhimurium andEscherichia coli

(2011) Minsik Kim et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant

(2011) D. K. Pomakova et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand

(2011) Camilla H. Lester et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Bacteriophages for the treatment of Pseudomonas aeruginosa infections

(2011) D.R. Harper et al.   JOURNAL OF APPLIED MICROBIOLOGY

Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention

(2011) Eric Morello et al.   PLoS One

Comparative Effects of Carbapenems on Bacterial Load and Host Immune Response in aKlebsiella pneumoniaeMurine Pneumonia Model

(2010) Jamese J. Hilliard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

AcuteKlebsiella pneumoniaepneumonia alone and with concurrent infection: comparison of clinical and thin-section CT findings

(2010) F Okada et al.   BRITISH JOURNAL OF RADIOLOGY

Phage Therapy in Clinical Practice: Treatment of Human Infections

(2010) Elizabeth Kutter et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

(2010) Elizabeth B. Hirsch et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus

(2009) Michał Zimecki et al.   BMC MICROBIOLOGY

Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice

(2008) S. Chhibber et al.   JOURNAL OF MEDICAL MICROBIOLOGY